… factors are potential targets for antiviral therapy. Hence, in this study, the current therapeutic
strategies of COVID-19 have been classified into “target virus” and “target host” categories. …

… coronavirus 2 (SARS-CoV-2) emerged as a novel pathogen that causes coronavirus disease
2019 (COVID-19). … and clinical drugs that precisely target three different, essential steps of …

… (234) NSC61610 (Figure 20) induces lanthionine synthetase C-like 2 (LANCL2), a
therapeutic target for treating infectious diseases such as IFV-A infection. (235) The Ligustrum …

… for the treatment of COVID-19, several therapeutics and drugs … is to summarize three
therapeutic targets (proteases: RNA-… for further drug discovery to combat COVID-19. Both M pro …

… DUB and DUB-like proteases are under investigation as therapeutic targets for other
human diseases, but no inhibitors of these proteins have yet been approved 70 . Future …

… The ongoing episode of coronavirus disease 19 (COVID-19) has imposed a serious threat
… The causative agent of COVID-19 is a novel coronavirus known as SARS-CoV-2. The virus …

… Here, we summarized the current understanding of the hallmarks of COVID‐19 metabolism.
… to uncover new therapeutic targets. The efficacy of metabolic inhibitors against COVID‐19 is …

… therapy. In this article, we provide the perspectives of a rheumatologist on COVID-19, …
We also discuss potential therapeutic targets for management of COVID-19, some of which …

… coronavirus 2, we highlight the importance of the inflammasome pathway. We discuss available
pharmaceutical agents that target … target for the treatment of severe coronavirus disease …

… therapy. There … COVID-19. This review provides currently available information and insight
into pathophysiology of the disease, potential targets, and relevant clinical trials for COVID-19. …